DoubleLine ETF Adviser’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$658K Sell
30,759
-5,087
-14% -$94.9K 0.27% 99
2026
Q1
$589K Sell
35,846
-9,040
-20% -$155K 0.22% 106
2025
Q4
$722K Buy
44,886
+1,654
+4% +$29.2K 0.22% 107
2025
Q3
$828K Buy
43,232
+2,382
+6% +$42.7K 0.25% 102
2025
Q2
$715K Buy
40,850
+248
+0.6% +$4.41K 0.23% 100
2025
Q1
$821K Sell
40,602
-9,936
-20% -$201K 0.27% 95
2024
Q4
$1.02M Buy
50,538
+336
+0.7% +$7.28K 0.28% 95
2024
Q3
$1.15M Buy
+50,202
New +$1.08M 0.28% 92
2024
Q2
Sell
-53,738
Closed -$1.01M 198
2024
Q1
$1.01M Buy
53,738
+16,145
+43% +$293K 0.26% 94
2023
Q4
$744K Buy
+37,593
New +$661K 0.22% 106
2023
Q2
Sell
-27,031
Closed -$594K 187
2023
Q1
$594K Buy
27,031
+3,155
+13% +$78.2K 0.25% 89
2022
Q4
$599K Buy
+23,876
New +$580K 0.31% 86

Other funds holding DOC

DoubleLine ETF Adviser's DOC Position: Q2 2026 in Review

DoubleLine ETF Adviser reduced its Healthpeak Properties (DOC) stake by 14% in Q2 2026, selling an estimated $94.9K and leaving 30,759 shares worth $658K. The position accounts for 0.27% of the portfolio, ranked #99.

DoubleLine ETF Adviser first reported a position in DOC in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.15M in Q3 2024. 759 funds tracked by Wall St. Rank hold DOC as of Q2 2026.

  • DoubleLine ETF Adviser held 30,759 shares of Healthpeak Properties worth $658K as of Q2 2026.
  • DoubleLine ETF Adviser sold 5,087 Healthpeak Properties shares in Q2 2026, an estimated $94.9K.
  • Healthpeak Properties made up 0.27% of DoubleLine ETF Adviser's portfolio in Q2 2026, its #99 holding.
  • DoubleLine ETF Adviser first reported a position in Healthpeak Properties in Q4 2022 and has held it in 12 quarters since.
  • DoubleLine ETF Adviser's Healthpeak Properties position peaked at $1.15M in Q3 2024.
  • 759 funds tracked by Wall St. Rank held Healthpeak Properties as of Q2 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.